These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26372386)

  • 1. The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals.
    Kohler I; Kouyos R; Bianchi M; Grube C; Wyrzucki A; Günthard HF; Hangartner L
    AIDS; 2015 Sep; 29(14):1803-10. PubMed ID: 26372386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.
    Kohler I; Scherrer AU; Zagordi O; Bianchi M; Wyrzucki A; Steck M; Ledergerber B; Günthard HF; Hangartner L
    Clin Infect Dis; 2014 Nov; 59(10):1386-93. PubMed ID: 25139962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Luo Z; Ma L; Zhang L; Martin L; Wan Z; Warth S; Kilby A; Gao Y; Bhargava P; Li Z; Wu H; Meissner EG; Li Z; Kilby JM; Liao G; Jiang W
    Vaccine; 2016 Apr; 34(16):1945-55. PubMed ID: 26721328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults.
    Kikuchi T; Iwatsuki-Horimoto K; Adachi E; Koga M; Nakamura H; Hosoya N; Kawana-Tachikawa A; Koibuchi T; Miura T; Fujii T; Kawaoka Y; Iwamoto A
    Vaccine; 2012 Jun; 30(26):3819-23. PubMed ID: 22504038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
    Bailey JR; Dowd KA; Snider AE; Osburn WO; Mehta SH; Kirk GD; Thomas DL; Ray SC
    J Infect Dis; 2015 Sep; 212(6):914-23. PubMed ID: 25754978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
    Tremblay CL; Rouleau D; Fortin C; Toma E; Sylla M; Cyr L; Cote S; Baz M; Sampalis J; Trautman L; Sékaly RP; Boivin G
    Vaccine; 2011 Feb; 29(7):1359-63. PubMed ID: 21185423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.
    Karlsson Hedestam GB; Fouchier RA; Phogat S; Burton DR; Sodroski J; Wyatt RT
    Nat Rev Microbiol; 2008 Feb; 6(2):143-55. PubMed ID: 18197170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies.
    Sui J; Sheehan J; Hwang WC; Bankston LA; Burchett SK; Huang CY; Liddington RC; Beigel JH; Marasco WA
    Clin Infect Dis; 2011 Apr; 52(8):1003-9. PubMed ID: 21460314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.
    Parmigiani A; Alcaide ML; Freguja R; Pallikkuth S; Frasca D; Fischl MA; Pahwa S
    PLoS One; 2013; 8(11):e79816. PubMed ID: 24236161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
    Yanagisawa N; Maeda K; Ajisawa A; Imamura A; Suganuma A; Ando M; Takayama N; Okuno Y
    Vaccine; 2011 Aug; 29(34):5694-8. PubMed ID: 21689709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.
    George VK; Pallikkuth S; Parmigiani A; Alcaide M; Fischl M; Arheart KL; Pahwa S
    J Infect Dis; 2015 Jun; 211(12):1959-68. PubMed ID: 25556252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.
    Nunes MC; Cutland CL; Dighero B; Bate J; Jones S; Hugo A; van Niekerk N; Kuwanda L; Izu A; Weinberg A; Madhi SA;
    J Infect Dis; 2015 Dec; 212(12):1976-87. PubMed ID: 26080370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.